Precision Synergy in Cancer Treatment

Dear Colleagues,

Cancer treatment has progressed from unimodal interventions to advanced multimodal strategies integrating surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy. This integrated strategy concurrently targets multiple tumor vulnerabilities, optimizing therapeutic outcomes, overcoming drug resistance, and mitigating toxicity. In addition, many precision management techniques, such as the use of novel drugs for immunotherapy, organoid technology for cancer research, radiation protection drugs to reduce the level of damage induced by radiation, the application of artificial intelligence in cancer prediction and diagnosis, etc., are widely applied in the field of cancer. Such innovations are transforming clinical paradigms—for instance, in lung cancer—and facilitating long-term survival for an increasing number of patients. This Special Issue aims to showcase cutting-edge innovations in combination therapies, emphasizing novel predictive methodologies, therapeutic management approaches, and the strategic orchestration of diverse treatment modalities in order to develop new therapeutic strategies to improve cancer treatment and patient survival.

Dr. Shigao Huang
Dr. Ammad Ahmad Farooqi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.